查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576939

數位/電力血壓計:市場洞察·競爭環境·市場預測 (～2030年)

Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

數位/電子血壓計市場規模預計將從 2023 年的 9.7778 億美元成長到 2030 年的 17.8388 億美元，預計 2024-2030 年的複合年增長率將達到 10.57%。

高血壓和其他心血管疾病發生率的增加刺激了對定期血壓監測的需求，推動了數位/電子血壓計市場的發展。這些疾病通常需要持續監測來管理風險，促使對家庭設備的依賴增加。健康意識的提高正在推動定期監測，數位血壓計因其易用性和便攜性而越來越受歡迎。此外，藍牙連接和智慧型手機整合等持續的技術創新正在增加其對消費者和醫療保健提供者的吸引力，進一步推動市場成長。這些擴大的治療選擇和日益激烈的競爭預計將改善患者的治療效果並推動 2024 年至 2030 年的市場成長。

數位/電動血壓計市場動態：

根據世界衛生組織 (WHO) 2023 年的最新數據，全球估計有 12.8 億 30 歲至 79 歲的成年人患有高血壓，其中大多數（三分之二）患有低血壓。收入國家。據估計，有 46% 的成人高血壓患者不知道自己的症狀，只有不到一半 (42%) 得到診斷和治療。

根據英國心臟基金會2024年的最新數據，全球約有6.2億人（約13人中就有1人）患有心臟和循環系統疾病。此外，同一數據顯示，2021年，歐洲有1億人患有心臟和循環系統疾病，亞洲和澳洲有3.4億人患有心臟病和循環系統疾病。此外，缺血性冠狀動脈心臟病是全世界最常診斷的疾病，影響估計2億人。約 1.1 億男性和 8,000 萬名女性受到影響。

高血壓是多種心血管疾病的主要危險因素，包括心臟病、中風和心臟衰竭，因此需要定期準確監測血壓，以有效控制這些疾病的發生。因此，數位血壓計具有用戶友好的介面、便攜性以及無需大量醫療培訓即可提供可靠讀數的能力，是患者和醫療保健提供者的必備工具。

除上述因素外，數位/電子血壓計領域的技術進步，例如開發新技術以提高診斷準確性，預計也將有助於數位/電子血壓計市場的成長。

本報告提供全球數位/電力血壓計的市場調查，提供市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 數位/電力血壓計市場:簡介

第2章 數位/電力血壓計市場:摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 數位/電力血壓計市場:主要要素分析

  • 推動市場要素
    • 高血壓、心血管疾病和其他循環系統疾病的發生率增加
    • 提高健康意識
    • 數位/電子血壓計領域的技術進步
  • 阻礙市場要素·課題
    • 有關數位/電子血壓計的準確性問題
    • 需要不斷重新校準血壓計
  • 市場機會
    • 穿戴式裝置的出現/越來越多地轉向遠距病患監護

第6章 數位/電力血壓計市場:波特的五力分析

第7章 數位/電力血壓計市場:市場評估

  • 各產品類型
    • 上臂
    • 手腕
  • 各技術
    • 完全自動
    • 半自動
  • 可攜帶性
    • 可攜式
    • 非可攜式
  • 各終端用戶
    • 醫院·診所
    • 門診病人診療中心
    • 居家照護
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 數位/電力血壓計市場:企業·產品簡介

  • OMRON Healthcare, Inc.
  • Hill-Rom Services, Inc.
  • A&D Company Limited
  • SunTech Medical, Inc.
  • American Diagnostic Corporation
  • Withings
  • General Electric Company
  • Microlife Corporation
  • GF Health Products, Inc.
  • Spacelabs Healthcare
  • Rudolf Riester GmbH
  • Contec Medical Systems Co., Ltd.
  • ARCHOS(TM)
  • Panasonic Corporation
  • Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
  • ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
  • BOSCH + SOHN GmbH u. Co. KG.
  • Beijing Choice Electronic Tech Co., Ltd.
  • Koninklijke Philips N.V.
  • SPENGLER HOLTEX Group

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明·諮詢方式

Product Code: DIMDCL0246

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of hypertension, other circulatory system disorders, and growing technological advancements in the field of digital/electrical sphygmomanometer.

The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030. The increasing incidence of hypertension and other circulatory disorders has fueled the demand for regular blood pressure monitoring, driving the market for digital/electrical sphygmomanometers. These disorders often require continuous monitoring to manage risks, which increases reliance on home-use devices. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

Digital/Electrical Sphygmomanometer Market Dynamics:

As per the latest data provided by World Health Organization (2023), an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension, with most (two-thirds) residing in low- and middle-income countries. An estimated 46% of adults with hypertension were unaware of their condition, and less than half (42%) had been diagnosed and treated.

According to a recent data provided by British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, lived with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, was the most commonly diagnosed worldwide, affected an estimated 200 million people globally. Approximately 110 million men and 80 million women were affected. Additionally, around 56 million women and 45 million men were stroke survivors. It was estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed.

As hypertension is a major risk factor for various cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an increasing need for regular and accurate monitoring of blood pressure to manage these diseases effectively. Thus, digital sphygmomanometers, with their user-friendly interfaces, portability, and ability to provide reliable readings without requiring extensive medical training, have become indispensable tools for both patients and healthcare providers thereby escalating the overall market of digital/electrical sphygmomanometer across the globe.

Along with the factors mentioned above, technological advancements in the field of digital/electrical sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the digital/electrical sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.

However, digital/electrical sphygmomanometer being very sensitive due to which body movements affect its accuracy and the need for continuous recalibration of the devices may be certain limiting factors of the digital/electrical sphygmomanometer market growth.

Digital/Electrical Sphygmomanometer Market Segment Analysis:

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall digital/electrical sphygmomanometer market, the wrist type digital/electrical sphygmomanometer are expected to hold the largest share in the year 2023. Wrist-worn digital/electrical sphygmomanometers are playing a significant role in boosting the overall market for blood pressure monitoring devices. Their unique design and user-friendly features cater to a growing demand for convenience, portability, and real-time health monitoring, contributing to their increasing popularity among consumers and healthcare providers alike.

Additionally, the primary advantages of wrist-worn sphygmomanometers is their portability. Wrist-worn models are compact and lightweight, making them ideal for users who need to monitor their blood pressure regularly while on the go. This convenience appeals to a broad range of consumers, including those who travel frequently or have busy lifestyles, thereby expanding the market reach of digital sphygmomanometers. These devices are typically easier to position and operate than their upper-arm counterparts, which can be especially beneficial for elderly users or individuals with limited mobility. The simplicity of wrist-worn sphygmomanometers encourages more frequent monitoring, aligning with the growing trend of proactive health management. As people become more aware of the importance of tracking their blood pressure regularly to prevent or manage conditions like hypertension, the demand for user-friendly, accessible devices increases, further boosting the market.

Furthermore, the technological advancements in wrist-worn digital sphygmomanometers are also contributing to their rising popularity. Modern devices often feature integration with smartphones and other digital health platforms, allowing users to easily track and analyze their blood pressure data over time. This ability to monitor trends and share data with healthcare providers enhances the utility of wrist-worn devices, making them an attractive option for tech-savvy consumers and those managing chronic conditions. For instance, in June 2022, LiveMetric announced the launch of LiveOne, the world's first 510(k) FDA-cleared nano-sensor technology for continuous blood pressure monitoring. This wrist-worn, cuff-free device provided real-time measurements every 10 seconds, improving care for hypertension and cardiovascular patients. Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global digital/electrical sphygmomanometer market during the forecast period.

North America is expected to dominate the overall digital/electrical sphygmomanometer market:

Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases. Additionally, increasing health awareness, rising government initiatives, and increasing product launches and product approvals are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

According to the latest data provided by the Centre for Disease Control and Prevention (2023), approximately, 48.1% population of adults age 18 and older in the United States are living with hypertension. Additionally, as per the recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Additionally, each year, over 795,000 people in the U.S. experience a stroke, with around 610,000 of these being first-time strokes. Notably, nearly 185,000 of these strokes, or about one in four, occur in individuals who have previously had a stroke. With hypertension being a critical risk factor for cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an escalating need for reliable and consistent blood pressure monitoring. Digital sphygmomanometers, with their user-friendly design, portability, and precision, have become indispensable for effective disease management. This trend is accelerating the growth of the digital/electrical sphygmomanometers across the region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for digital/electrical sphygmomanometer. For instance, in March 2021, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device.

Therefore, the above-mentioned factors are expected to bolster the growth of the digital/electrical sphygmomanometer market in the North America during the forecast period.

Digital/Electrical Sphygmomanometer Market Key Players:

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group, and others.

Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:

  • In January 2024, Nanowear announced the FDA 510(k) clearance for SimpleSense-BP, AI-enabled continuous blood pressure monitoring and for hypertension diagnostic management.
  • In August 2023, Corsano Health launched CardioWatch EU-MDR , a cuffless blood pressure monitor.
  • In September 2022, Gramin received FDA clearance for smart BPM Smart Blood Pressure Monitor.
  • In August 2022, Sensifree Ltd. Received CE certificate for SentiCor-100(R) in compliance with the new EU MDR.
  • In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS(TM) HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.

Key Takeaways From the Digital/Electrical Sphygmomanometer Market Report Study:

  • Market size analysis for current digital/electrical sphygmomanometer size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the digital/electrical sphygmomanometer market.
  • Various opportunities available for the other competitors in the digital/electrical sphygmomanometer market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current digital/electrical sphygmomanometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for digital/electrical sphygmomanometer market growth in the coming future?

Target Audience who can be Benefited From This Digital/Electrical Sphygmomanometer Market Report Study:

  • Digital/electrical sphygmomanometer product providers
  • Research organizations and consulting companies
  • Digital/electrical sphygmomanometer -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in digital/electrical sphygmomanometer
  • Various end-users who want to know more about the digital/electrical sphygmomanometer market and the latest technological developments in the digital/electrical sphygmomanometer market.

Frequently Asked Questions for the Digital/Electrical Sphygmomanometer Market:

1. What are digital/electrical sphygmomanometer?

  • Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer.

2. What is the market for digital/electrical sphygmomanometer?

  • The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030.

3. What are the drivers for the digital/electrical sphygmomanometer market?

  • The rising incidence of hypertension and other circulatory system disorders has driven demand for accurate, user-friendly blood pressure monitors. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

4. Who are the key players operating in the digital/electrical sphygmomanometer market?

  • Some of the key market players operating in the digital/electrical sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd., Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

5. Which region has the highest share in the digital/electrical sphygmomanometer market?

  • Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases, increasing health awareness, rising government initiatives, and increased government product regulations are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

Table of Contents

1. Digital/Electrical Sphygmomanometer Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Digital/Electrical Sphygmomanometer Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Digital/Electrical Sphygmomanometer Market Key Factors Analysis

  • 5.1. Digital/Electrical Sphygmomanometer Market Drivers
    • 5.1.1. Increasing incidence of hypertension, cardiovascular diseases, and other circulatory system disorders
    • 5.1.2. Increasing awareness for health
    • 5.1.3. Growing technological advancements in the field of digital/electrical sphygmomanometer
  • 5.2. Digital/Electrical Sphygmomanometer Market Restraints and Challenges
    • 5.2.1. Accuracy concerns related to digital/electrical sphygmomanometer
    • 5.2.2. Need for continuous recalibration of sphygmomanometer devices
  • 5.3. Digital/Electrical Sphygmomanometer Market Opportunities
    • 5.3.1. Increase in shift toward remote patient monitoring, combined with the emergence of wearable devices

6. Digital/Electrical Sphygmomanometer Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Digital/Electrical Sphygmomanometer Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Upper Arm
    • 7.1.2. Wrist Type
  • 7.2. By Technology
    • 7.2.1. Full-Automatic
    • 7.2.2. Semi-Automatic
  • 7.3. By Portability
    • 7.3.1. Portable
    • 7.3.2. Non-Portable
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Care Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.1.2. Canada Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.1.3. Mexico Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.2. Germany Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.3. United Kingdom Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.4. Italy Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.5. Spain Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.2.6. Rest of Europe Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.2. Japan Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.3. India Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.4. Australia Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.5. South Korea Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.4.2. Africa Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
      • 7.5.4.3. South America Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)

8. Digital/Electrical Sphygmomanometer Market Company and Product Profiles

  • 8.1. OMRON Healthcare, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Hill-Rom Services, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. A&D Company Limited
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SunTech Medical, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. American Diagnostic Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Withings
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. General Electric Company
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Microlife Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. GF Health Products, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Spacelabs Healthcare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Rudolf Riester GmbH
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Contec Medical Systems Co., Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. ARCHOS(TM)
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Panasonic Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. BOSCH + SOHN GmbH u. Co. KG.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Beijing Choice Electronic Tech Co., Ltd.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Koninklijke Philips N.V.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. SPENGLER HOLTEX Group
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Table 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Table 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Table 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Table 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
  • Table 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Table 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Table 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
  • Table 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Table 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Table 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Table 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Table 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Table 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
  • Table 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Table 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Table 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
  • Table 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
  • Table 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Table 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Table 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Table 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Table 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Table 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
  • Table 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
  • Table 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Table 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
  • Figure 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
  • Figure 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
  • Figure 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
  • Figure 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
  • Figure 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
  • Figure 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
  • Figure 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
  • Figure 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
  • Figure 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
  • Figure 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
  • Figure 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
  • Figure 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
  • Figure 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
  • Figure 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
  • Figure 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
  • Figure 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
  • Figure 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
  • Figure 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
  • Figure 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
  • Figure 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
  • Figure 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
  • Figure 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
  • Figure 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
  • Figure 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
  • Figure 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
  • Figure 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis